GGrantIndex
← Leaderboards

Marco Brotto

University Of Missouri Kansas City

$8,566,140
Attributed
$14,375,999
Total exposure
8
Grants
2
Lead (contact PI)

Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.

Funding over time

peak $2.3M · FY200923
$2.5M$1.9M$1.3M$625K$0
'09
'10
'11
'12
'13
'14
'15
'16
'17
'18
'19
'20
'21
'22
'23

Funding mix

By agency

NIH$14,375,999 · 8

By mechanism

R01$9,873,111 · 4
P01$3,115,375 · 2
RC2$1,077,285 · 1
R56$310,228 · 1

Others in their field

Top investigators on “Muscle

Research focus

MuscleMuscle FunctionMolecularLinkSkeletal MuscleRegulationGenesSignal TransductionAgingMediatingMuscle FibersMuscle FormSarcopeniaFunctional DisorderBiochemicalImpairmentMuscle WeaknessMuscular AtrophyMuscle AgingQuality Of LifeKnockout MiceLipidsProductionSkeletal Muscle Wasting

Grant awards (35)

Preserving Mitochondrial Function for Alleviating ALS Progression$554,482
R01 · FY2023 · NS
Protecting the Diabetic Skeletal Muscle by Nampt Activation$364,759
R01 · FY2023 · DK
Preserving mitochondrial function for alleviating ALS progression$570,776
R01 · FY2022 · NS
Regulation of Store-Operated Calcium Entry During Muscle Aging$494,339
R01 · FY2022 · AG
Loss of Numb in Muscle Dysfunction in Aging$446,969
R01 · FY2022 · AG
Protecting the Diabetic Skeletal Muscle by Nampt Activation$407,887
R01 · FY2022 · DK
Effects of Osteocyte Factors, WNT3a and PGE2, on Muscle with Aging$336,537
P01 · FY2022 · AG · contact PI
Loss of Numb in Muscle Dysfunction in Aging$54,825
R01 · FY2022 · AG
Loss of Numb in Muscle Dysfunction in Aging$27,412
R01 · FY2022 · AG
Preserving mitochondrial function for alleviating ALS progression$591,508
R01 · FY2021 · NS
Regulation of Store-Operated Calcium Entry During Muscle Aging$502,318
R01 · FY2021 · AG
Loss of Numb in Muscle Dysfunction in Aging$458,565
R01 · FY2021 · AG
Protecting the Diabetic Skeletal Muscle by Nampt Activation$409,826
R01 · FY2021 · DK
Effects of Osteocyte Factors, WNT3a and PGE2, on Muscle with Aging$342,149
P01 · FY2021 · AG · contact PI
Preserving mitochondrial function for alleviating ALS progression$578,155
R01 · FY2020 · NS
Regulation of Store-Operated Calcium Entry During Muscle Aging$510,119
R01 · FY2020 · AG
Loss of Numb in Muscle Dysfunction in Aging$466,559
R01 · FY2020 · AG
Protecting the Diabetic Skeletal Muscle by Nampt Activation$409,106
R01 · FY2020 · DK
Effects of Osteocyte Factors, WNT3a and PGE2, on Muscle with Aging$338,232
P01 · FY2020 · AG · contact PI
Preserving mitochondrial function for alleviating ALS progression$583,090
R01 · FY2019 · NS
Regulation of Store-Operated Calcium Entry During Muscle Aging$517,747
R01 · FY2019 · AG
Loss of Numb in Muscle Dysfunction in Aging$472,304
R01 · FY2019 · AG
Protecting the Diabetic Skeletal Muscle by Nampt Activation$433,699
R01 · FY2019 · DK
Effects of Osteocyte Factors, WNT3a and PGE2, on Muscle with Aging$340,972
P01 · FY2019 · AG · contact PI
Regulation of Store-Operated Calcium Entry During Muscle Aging$539,210
R01 · FY2018 · AG
Loss of Numb in Muscle Dysfunction in Aging$479,456
R01 · FY2018 · AG
Effects of Osteocyte Factors, WNT3a and PGE2, on Muscle with Aging$361,688
P01 · FY2018 · AG · contact PI
Osteocyte Modulatin of muscle function during aging$282,359
P01 · FY2016 · AG · contact PI
MG29 function in regulation of Store-Operated Calcium Entry during Muscle Aging$310,228
R56 · FY2015 · AG
Osteocyte Modulatin of muscle function during aging$281,892
P01 · FY2015 · AG · contact PI
Osteocyte Modulatin of muscle function during aging$282,359
P01 · FY2014 · AG · contact PI
Osteocyte Modulatin of muscle function during aging$266,828
P01 · FY2013 · AG · contact PI
Osteocyte Modulatin of muscle function during aging$282,359
P01 · FY2012 · AG · contact PI
Muscle-Bone Endocrine Axis$527,140
RC2 · FY2010 · AR
Muscle-Bone Endocrine Axis$550,145
RC2 · FY2009 · AR